首页> 外文期刊>Indian journal of Anaesthesia >Retrospective analysis of risk factors of postoperative nausea and vomiting in patients undergoing ambulatory strabismus surgery via general anaesthesia
【24h】

Retrospective analysis of risk factors of postoperative nausea and vomiting in patients undergoing ambulatory strabismus surgery via general anaesthesia

机译:通过全身麻醉术后术后恶心危险因素的回顾性分析,呕吐术语

获取原文
           

摘要

Background and Aims: Postoperative nausea and vomiting (PONV), one of the common complications following strabismus surgery, would delay the ambulatory discharge time. The aim of this retrospective study was to determine the risk factors of PONV in patients undergoing ambulatory strabismus surgery under general anaesthesia, with the treatments of dexamethasone and 5-HTsub3/subantagonist combination. Methods: We reviewed 721 consecutive patients (12–60 years old) undergoing ambulatory strabismus surgery under general anaesthesia at an academic eye centre between December 2016 and January 2019. Patients received prophylactic treatment of dexamethasone and 5-HTsub3/subantagonist combination during anaesthesia induction, and PONV was evaluated during the early recovery period before discharge. Results: The dexamethasone and 5-HTsub3/subantagonist combination effectively reduced the incidence of PONV (3.05%, 22/721), and the patients who experienced PONV had statistically prolonged phase II recovery time as compared those who did not (P = 0.006). The sum of the extraocular muscles manipulated and the use of nalbuphine (vs flurbiprofen axetil) were the independent risk factors for PONV (P 0.05). Conclusion: The sum of the extraocular muscles manipulated and the use of nalbuphine are potentially modifiable risk factors for PONV after strabismus surgery with the treatments of dexamethasone and 5-HTsub3/subantagonist combination.
机译:背景和目的:术后恶心和呕吐(PONV),斜视手术后的常见并发症之一,会延迟动态放电时间。该回顾性研究的目的是确定在全身麻醉下进行动态斜视手术的患者患者的PONV的危险因素,其治疗地塞米松和5-HT 3 拮抗剂组合。方法:在2016年12月至2019年1月期间,在一般麻醉下,在一般麻醉下,在一般麻醉下,在2016年12月至2019年1月期间接受了721名连续患者(12-60岁)。患者接受了地塞米松的预防治疗和5-HT 3 在麻醉期间的拮抗剂组合在出院前的早期恢复期间评价突出。结果:地塞米松和5-HT 3 拮抗剂组合有效降低了PONV的发生率(3.05%,22/721),而经历过PONV的患者在统计上延长了第二阶段恢复时间没有(p = 0.006)。被操纵和使用纳丙啡(VS Flurbrofen Axetil)的床上肌肉的总和是PONV的独立风险因素(P <0.05)。结论:用斜视手术治疗地塞米松和5-HT 3 拮抗剂组合的治疗后术后植物肌肉和使用Nalbuphine的潜在危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号